Merontos, Angelic H.
HRN: 22-47-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/16/2023
IV
2g
OD
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes